Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
about
Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis.Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritisSpatial analyzes of HLA data in Rio Grande do Sul, south Brazil: genetic structure and possible correlation with autoimmune diseases
P2860
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anticollagen type II antibodie ...... tion during 5 years follow-up.
@en
type
label
Anticollagen type II antibodie ...... tion during 5 years follow-up.
@en
prefLabel
Anticollagen type II antibodie ...... tion during 5 years follow-up.
@en
P2093
P2860
P50
P1476
Anticollagen type II antibodie ...... tion during 5 years follow-up.
@en
P2093
Helga Westerlind
Johan Rönnelid
Mohammed Mullazehi
Saedis Saevarsdottir
Vivek Anand Manivel
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-210873
P407
P577
2017-03-23T00:00:00Z